Vascular Dementia Clinical Trials

16 recruiting

Vascular Dementia Trials at a Glance

14 actively recruiting trials for vascular dementia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Malmö, Toronto, and Guangzhou. Lead sponsors running vascular dementia studies include Skane University Hospital, Center for Eye Research Australia, and Center for Clinical Studies, Texas.

Browse vascular dementia trials by phase

Treatments under study

About Vascular Dementia Clinical Trials

Looking for clinical trials for Vascular Dementia? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vascular Dementia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vascular Dementia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

DementiaAlzheimer DiseaseParkinson Disease+5 more
Center for Eye Research Australia930 enrolled1 locationNCT07545473
Recruiting

The Swedish BioFINDER - Primary Care Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06120361
Recruiting

The Swedish BioFINDER - Memory Clinic Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06122415
Recruiting

Retinal Vessel Leakage in Cerebral Small Vessel Disease

Vascular DementiaCerebral Small Vessel DiseasesLacunar Stroke
University of Edinburgh40 enrolled1 locationNCT06416371
Recruiting

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Vascular DementiaHerpes Zoster (HZ)
Center for Clinical Studies, Texas375 enrolled2 locationsNCT06903078
Recruiting

Predictors of Emergency Department Use in Frail Patients

ElderlyFrailtyAlzheimer s Disease+3 more
University of Pisa110 enrolled1 locationNCT07259499
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment

Mild Cognitive ImpairmentVascular Dementia
Neurogrin Inc.24 enrolled1 locationNCT07149038
Recruiting

Cognitive and Vascular Functioning Following TBI

Traumatic Brain InjuryCognitive DeclineVascular Dementia
Walter Reed National Military Medical Center300 enrolled1 locationNCT06034509
Recruiting
Not Applicable

The BRAIN App (Phase 2 SBIR)

DementiaAlzheimer DiseaseVascular Dementia
Hopeful Aging120 enrolled1 locationNCT06298474
Recruiting
Not Applicable

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

Obstructive Sleep ApneaAlzheimer DiseaseMild Cognitive Impairment+1 more
Sunnybrook Health Sciences Centre200 enrolled1 locationNCT04335994
Recruiting
Not Applicable

Multidimensional Rehabilitation Programs for Cognitive Impairment in Comorbid Outpatients: a Randomized Controlled Trial

Comorbidities and Coexisting ConditionsCognitive ImpairmentDementia+2 more
Istituti Clinici Scientifici Maugeri SpA75 enrolled1 locationNCT05954741
Recruiting

Longitudinal Cognitive Assessment by BoCA

Multiple SclerosisAlzheimer DiseaseParkinson Disease+4 more
Alzheimer's Light LLC10,000 enrolled1 locationNCT04114994
Recruiting

Cognitive Impairment in Ageing People

Cognitive ImpairmentAlzheimer DiseaseMCI+1 more
Yamei Tang5,000 enrolled1 locationNCT04360200